通过无形固体分散系统推进植物提取物的物理化学特性和治疗潜力
Arif Budiman1, Nur Parida Mahdhani Hafidz2, Raden Siti Salma Azzahra2
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia.
Polymers
|January 8, 2025
概括
无形固体分散 (ASD) 提高了植物提取物的可溶性和生物可用性,克服了药物输送方面的挑战. 这些系统提高了治疗效率,并减少了药用植物应用的毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 自然产品 自然产品
背景情况:
- 植物提取物提供多样化的生物活动和低毒性,但面临着难以溶解和生物可用性的挑战.
- 药物输送的限制阻碍了植物性活性药物成分 (API) 的临床进步.
研究的目的:
- 审查植物提取物无形固体分散 (ASD) 系统的进展.
- 分析ASD对植物衍生API的表征,溶解和药理活性的影响.
主要方法:
- 对利用无形固体分散物用于植物提取物的研究进行文献综述.
- 对ASD系统的表征技术的分析.
- 评估ASD对溶解概况和生物可用性的影响.
主要成果:
- ASD系统显著提高了植物成分的溶解和生物可用性.
- 无形固体分散增强了植物提取物的稳定性和药理疗效.
- ASD配方可以导致剂量减少和毒性降低.
结论:
- 无形固体分散对于克服植物提取物药物输送的局限性至关重要.
- ASD技术增强了药用植物提取物的治疗潜力和临床适用性.
- 未来的研究表明,与植物提取物相结合的ASD系统有前途的治疗应用.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
114
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
114
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
281
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
281
Factors Affecting Dissolution: Particle Size and Effective Surface Area
719
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
719
Factors Influencing Drug Absorption: Physicochemical Parameters
214
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
214
Factors Influencing Drug Absorption: Drug Dissolution
408
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
408
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173


